Trial intelligence / Profile preview

Lorpiprazole hydrochloride for postoperative analgesia after hip or knee arthroplasty

CTR20181161Phase 2Active

Sponsor
Beijing Bridge Biopharmaceutical
Start
Jul 2018
Modality
Small Molecules
Countries
1
01

Overview

A Phase 2 trial of lorpiprazole in postoperative pain, sponsored by Beijing Bridge Biopharmaceutical. Started Jul 2018; status: active.

02

Drugs

lorpiprazole
03

Conditions

postoperative pain

Beyond the preview

Go deeper on CTR20181161.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on CTR20181161.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call